Share on LinkedInShare on LinkedIn

ARTICLE · 23 NOVEMBER 2015

The TPP — New Rights For Pharmaceutical Patent Holders In Canada

Gowling WLG
Gowling WLG
Contributor
Gowling WLG

Gowling WLG

The firm The firm’s lawyers speak English, French, Russian and Ukrainian. The firm’s client base...

View firm profile
Explore more from Gowling WLG

The Canadian government released the official consolidated text of the Trans-Pacific Partnership (TPP) agreement on Nov., 5, 2015.

CanadaIntellectual Property

The Canadian government released the official consolidated text of the Trans-Pacific Partnership (TPP) agreement on Nov., 5, 2015.1 This follows the technical summary of negotiated outcomes posted on the Department of Foreign Affairs and Development Canada's website following conclusion of the agreement.2

The Canadian government has not released any additional information as to how it will apply the TPP in Canada.  However, based on a review of the text of the TPP, patent holders can look forward to some additional patent rights, notably patent term extensions in certain situations.3  No changes are expected regarding patentable subject matter.4

Moreover, the TPP includes specific provisions for the pharmaceutical industry including explicit data protection for a broad range of pharmaceuticals, including new chemical entity based pharmaceuticals, clinical data for previously approved products, and biologics.5 The TPP also includes provisions on patent linkage and

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from